Sunshine Biopharma (SBFM) Other financing activities (2010 - 2019)
Sunshine Biopharma (SBFM) reported Other financing activities of $7590.0 for Q4 2019, down 98.92% on a YoY basis from $705568.0 in Q4 2018, and up 200.0% quarter-over-quarter from -$7590.0 in Q2 2019.
Sunshine Biopharma (SBFM) Other financing activities (2010 - 2019) Analysis & Trends
Sunshine Biopharma has reported Other financing activities for 10 years, with the latest figure at $7590.0 in Q4 2019.
- For the quarter ending Q4 2019, Other financing activities fell 98.92% year-over-year to $7590.0; the trailing twelve-month figure through Dec 2020 stood at $7590.0 (changed N/A YoY), and the FY2018 full-year result was $676100.0, up 58.19% from the prior year.
- Other financing activities for Q4 2019 stood at $7590.0, up from -$7590.0 in the prior quarter.
- The five-year high for Other financing activities was $705568.0 in Q4 2018, with the low at -$102002.0 in Q3 2018.
- Historically, Other financing activities has averaged $160191.7 across 5 years, with a median of $89200.0 in 2016.
- The largest YoY upside for Other financing activities was 1344.39% in 2018 against a maximum downside of 125.14% in 2018.
- Sunshine Biopharma's Other financing activities stood at $116500.0 in 2015, then jumped by 142.75% to $282800.0 in 2016, then plunged by 120.05% to -$56700.0 in 2017, then surged by 1344.39% to $705568.0 in 2018, then tumbled by 98.92% to $7590.0 in 2019.
- The last three Other financing activities figures came in at $7590.0 (Q4 2019), -$7590.0 (Q2 2019), and $705568.0 (Q4 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Sunshine Biopharma | 11.70 Mn | 4.79 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 7,590.00 |
| Dec 31, 2019 | 7,590.00 |
| Jun 30, 2019 | -7,590.00 |
| Jun 30, 2019 | -7,590.00 |
| Dec 31, 2018 | 705,568.00 |
| Dec 31, 2018 | 705,568.00 |
| Sep 30, 2018 | -102,002.00 |
| Sep 30, 2018 | -102,002.00 |
| Mar 31, 2018 | 72,534.00 |
| Mar 31, 2018 | 72,534.00 |
| Dec 31, 2017 | -56,700.00 |
| Dec 31, 2017 | -56,700.00 |
| Sep 30, 2017 | 405,700.00 |
| Sep 30, 2017 | 405,700.00 |
| Jun 30, 2017 | 78,400.00 |
| Jun 30, 2017 | 78,400.00 |
| Dec 31, 2016 | 282,800.00 |
| Dec 31, 2016 | 282,800.00 |
| Sep 30, 2016 | 319,500.00 |
| Sep 30, 2016 | 319,500.00 |